Investment Rating - The report rates the electric power equipment industry as "stronger than the market" [3]. Core Viewpoints - The demand for electric power equipment is driven by the growth of data centers, which are becoming the core incremental application scenario for the industry. The report emphasizes the need to incorporate AI industry indicators to accurately gauge the demand for power distribution equipment [3][6]. - Capital expenditures from major cloud providers are a direct indicator of demand potential for power distribution equipment, with significant growth observed in overseas capital expenditures [9][12]. - The supply chain remains robust, with companies like NVIDIA and TSMC showing strong revenue growth, indicating a healthy supply of GPUs essential for data center operations [18][24]. - The application layer is witnessing an increase in AI model deployments, which directly impacts capital expenditure cycles and long-term demand for power distribution equipment [29][30]. Summary by Sections Demand Side - The report highlights that overseas cloud providers' capital expenditures reached $99.617 billion in Q3 2025, a year-on-year increase of 80.39% and a quarter-on-quarter increase of 9.54% [9]. - Domestic capital expenditures from Alibaba and Tencent showed a slowdown, with Alibaba's capital expenditure at 315.01 million yuan, up 80.10% year-on-year but down 18.55% quarter-on-quarter [12][15]. Supply Chain - NVIDIA's data center product revenue reached 362.571 billion yuan in Q3 2025, marking a historical peak with a quarter-on-quarter growth of 24.62% and a year-on-year growth of 66.44% [18]. - TSMC's revenue in November 2025 was 343.614 billion New Taiwan dollars, a year-on-year increase of 24.5% [24]. Application Layer - The report notes a steady increase in AI model updates and application deployments, which are crucial for determining the strength and sustainability of capital expenditure cycles [29]. - The price of tokens for AI models has decreased by over 50% following the release of new models, indicating a competitive market [46]. Key Recommendations - The report recommends investing in companies like Sunshine Power (300274.SZ) and suggests paying attention to Keda Data (002335.SZ), Kstar (002518.SZ), and Kelon Electronics (002121.SZ) as beneficiaries of the growing demand for power distribution equipment driven by data centers [3].

证券研究报告 汽车 一年内行业指数与沪深 300 指数对比走势： 资料来源：聚源数据，爱建证券研究所 相关研究 《车企年销量目标完成度分化——智能汽车数 据销量跟踪（二）》2025-12-03 《蔚来业绩创历史新高，25Q4 有望实现盈利 ——智能汽车系列报告（五）》2025-12-03 《理想召回事件短期扰动业绩，静待 2026 年 产品升级——智能汽车系列报告（六）》 2025-12-01 《小鹏 25Q3 亏损收窄，盈利拐点在望——智 能汽车系列报告（四）》2025-11-19 《零跑 25Q3 盈利持续改善，技术普惠驱动销 量高增——智能汽车系列报告（三）》 2025-11-18 吴迪 S0820525010001 021-32229888-25523 wudi@ajzq.com 徐姝婧 S0820124090004 021-32229888-25517 xushujing@ajzq.com 行业及产业 曹操出行提"十年百城千亿"战略目标 ——Robotaxi 系列报告（二） 风险提示：技术长尾场景突破不及预期；行业监管政策变动影响落地节奏。 行业研究 / 行业点评 2025 年 12 月 12 日 ...

证券研究报告 行业研究 / 行业点评 2025 年 12 月 12 日 资料来源：聚源数据，爱建证券研究所 相关研究 《车企年销量目标完成度分化——智能汽车数 据销量跟踪（二）》2025-12-03 《蔚来业绩创历史新高，25Q4 有望实现盈利 ——智能汽车系列报告（五）》2025-12-03 《理想召回事件短期扰动业绩，静待 2026 年 产品升级——智能汽车系列报告（六）》 2025-12-01 《小鹏 25Q3 亏损收窄，盈利拐点在望——智 能汽车系列报告（四）》2025-11-19 《零跑 25Q3 盈利持续改善，技术普惠驱动销 量高增——智能汽车系列报告（三）》 2025-11-18 证券分析师 吴迪 S0820525010001 021-32229888-25523 wudi@ajzq.com 徐姝婧 S0820124090004 021-32229888-25517 xushujing@ajzq.com 汽车 一年内行业指数与沪深 300 指数对比走势： 评级说明 投资建议的评级标准 报告中投资建议所涉及的评级分为股票评级和行业评级（另有说明的除外）。评级标准为报告发布日后 6 个月内的相对市场 ...

证券研究报告 行业研究 / 行业点评 2025 年 12 月 12 日 汽车 徐姝婧 S0820124090004 021-32229888-25517 xushujing@ajzq.com 一年内行业指数与沪深 300 指数对比走势： 资料来源：聚源数据，爱建证券研究所 相关研究 《车企年销量目标完成度分化——智能汽车数 据销量跟踪（二）》2025-12-03 《蔚来业绩创历史新高，25Q4 有望实现盈利 ——智能汽车系列报告（五）》2025-12-03 《理想召回事件短期扰动业绩，静待 2026 年 产品升级——智能汽车系列报告（六）》 2025-12-01 《小鹏 25Q3 亏损收窄，盈利拐点在望——智 能汽车系列报告（四）》2025-11-19 《零跑 25Q3 盈利持续改善，技术普惠驱动销 量高增——智能汽车系列报告（三）》 2025-11-18 吴迪 S0820525010001 021-32229888-25523 wudi@ajzq.com 联系人 行业及产业 奔驰 Robotaxi 于阿布扎比开启路测 ——Robotaxi 系列报告（一） 强于大市 事件概要：12 月 9 日，梅赛德斯-奔驰 ...

证券研究报告 公司研究 / 公司点评 2025 年 12 月 12 日 收购光学镀膜装备公司，加速关键环节国产替代 电子 / 半导体 | 报告原因： | | | --- | --- | | 买入（维持） | | | 市场数据： | 2025 年 12 月 11 日 | | 收盘价（元） | 453.10 | | 一年内最高/最低（元） | 468.00/314.33 | | 市净率 | 9.1 | | 股息率（分红/股价） | 0.17 | | 流通 A 股市值（百万元） | 327,998 | | 上证指数/深证成指 | 3,873/13,147 | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据： | | | | 2025 | 年 | 09 | 月 30 | 日 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 每股净资产（元） | | | | | | | | | 49.8 | | 资产负债率% | | | | | | | 50.90 | | | | 总股本/流通 | | A | 股（百万） | | | ...

证券研究报告 公司研究 / 首次覆盖 2025 年 12 月 11 日 掌握精密加工全链路，积极布局机器人 汽车 ——铁流股份(603926.SH)首次覆盖 报告原因： | 市场数据： | 2025 | 年 | 12 月 | 10 | 日 | | --- | --- | --- | --- | --- | --- | | 收盘价（元） | | | | 16.01 | | | 一年内最高/最低（元） | | | | 18.75/7.72 | | | 市净率 | | | | 2.2 | | | 股息率（分红/股价） | | | | 1.63 | | | 流通 A 股市值（百万元） | | | | 3,696 | | | 上证指数/深证成指 | | | 3,900/13,316 | | | | 注："股息率"以最近一年已公布分红计算 | | | | | | | 基础数据： | | 2025 | 年 | 09 | 月 30 | | | 日 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 每股净资产（元） | | | | | | 7.4 | | | ...

Investment Rating - The report rates the pharmaceutical and biotechnology industry as "Outperforming the Market" [1][8]. Core Insights - The report highlights a significant increase in the success rate of negotiations for high-value innovative drugs, with the 2025 National Medical Insurance Directory adding 114 new drugs, including 50 innovative drugs, and achieving a negotiation success rate of 88%, up from 76% in 2024 [3]. - The introduction of a commercial insurance drug directory marks a new phase in healthcare, aiming to create a multi-layered insurance system that complements basic medical insurance, with 19 innovative drugs included in the first version [3]. - The report emphasizes the potential for Chinese innovative drugs to expand internationally, with a focus on ADCs, bispecific antibodies, small nucleic acids, and weight-loss drugs as key investment opportunities [3]. Summary by Sections Industry Performance - The SW Pharmaceutical and Biotechnology Index decreased by 0.74% in the week of December 1-7, underperforming the Shanghai and Shenzhen 300 Index, which increased by 1.28% [2]. - Within the pharmaceutical sector, the drug distribution (+6.48%) and offline pharmacy (+1.85%) segments performed relatively well, while raw materials (-2.54%), vaccines (-1.62%), and CXO (-1.29%) segments showed weaker performance [2]. National Medical Insurance Directory - The 2025 version of the National Medical Insurance Directory will officially implement on January 1, 2026, with a total of 3,253 drugs included, enhancing coverage for critical areas such as oncology, chronic diseases, mental health, rare diseases, and pediatric medications [3]. - Notably, 105 of the newly added drugs are exclusive products, including 98 Western medicines and 7 traditional Chinese medicines [3]. Commercial Insurance Drug Directory - The first version of the commercial insurance innovative drug directory includes 19 drugs, focusing on high clinical value and significant patient benefits, which are beyond the scope of basic medical insurance [5]. - This directory includes treatments for rare diseases, cancer therapies, and Alzheimer's disease, establishing a foundation for the development of a multi-tiered medical insurance system [3][5]. Investment Recommendations - The report suggests a positive outlook for the international expansion of Chinese innovative drugs and recommends monitoring ADCs, bispecific antibodies, small nucleic acids, and weight-loss drugs for investment opportunities [3]. - Key companies to watch include Yiming Biotechnology-B, WuXi AppTec, Maiwei Biotechnology-U, Kelun-Biotech, and Kangfang Biotech [3].

Investment Rating - The industry investment rating is "Outperform the Market" [2][31]. Core Insights - The demand for power and energy storage lithium batteries is growing, with significant increases in production and stable material prices observed [2][5]. - In November 2025, domestic battery production reached 170.6 GWh, a year-on-year increase of 50.84% and a month-on-month increase of 12.83% [2]. - The production of lithium iron phosphate (LFP) cathode materials in November 2025 was 268,900 tons, up 29.43% year-on-year and 0.75% month-on-month, with a capacity utilization rate of 62.53% [2]. - The average price of industrial-grade lithium carbonate as of November 28, 2025, was 90,900 CNY/ton, reflecting a weekly decrease of 0.55% [2]. - The average price of LFP (power type) remained stable at 39,100 CNY/ton as of November 28, 2025 [2]. - The demand for LFP batteries in October 2025 reached a monthly shipment of 67.5 GWh, a year-on-year increase of 43.62% [2]. - The export volume of Chinese power batteries in October 2025 was 19.4 GWh, a year-on-year increase of 79.63% [2]. Summary by Sections Production - In November 2025, the production of cathode materials showed a year-on-year increase, with significant growth in battery production compared to the same period in 2024 [2][3]. Prices - The prices of key raw materials for lithium batteries have stabilized, with notable price points for lithium carbonate, LFP, and lithium hexafluorophosphate [2][3]. Domestic Demand - The domestic demand for lithium batteries is robust, with new energy storage projects showing increased tender capacity compared to 2024 [2][3]. Overseas Demand - The overseas demand is also strong, with significant increases in exports of power batteries and global new energy vehicle sales [2][3].

Investment Rating - The report rates the industry as "Outperforming the Market" [3][20]. Core Insights - The liquor industry is entering a phase of rapid performance clearing, with demand expected to show weak recovery as policy pressures ease. The industry is currently at a low valuation, and pessimistic expectations are fully priced in, indicating a clearer direction for future industry clearing [2]. - The report emphasizes the importance of focusing on high-growth consumer goods sectors, where new products and channels are expected to drive market interest and valuation premiums for "scarce" growth targets [2]. - The report highlights the strategic responses of leading companies like Shanxi Fenjiu and Wuliangye to industry adjustments, focusing on brand value maintenance and consumer-driven strategies [3]. Summary by Sections Liquor Sector - The liquor sector is expected to see a weak recovery in demand due to easing policy pressures, with leading companies like Guizhou Moutai and Shanxi Fenjiu being recommended for their stable pricing and strong dividend yields [2]. - Shanxi Fenjiu's 2025 global dealer conference outlined a focus on national expansion, youth engagement, and precise consumer targeting, indicating a proactive approach to market share growth during industry adjustments [3]. - Wuliangye has adjusted its 2025 investment plan, reducing total investment while increasing brand promotion efforts, aiming to stabilize pricing and maintain brand integrity amid market discussions about price reductions [3]. Consumer Goods Sector - The report suggests focusing on high-growth consumer goods, with companies like Wancheng Group and Dongpeng Beverage showing promising growth trajectories [2]. - The consumer goods sector is characterized by ongoing innovation and new channel development, which are expected to attract market interest and valuation premiums [2].

Investment Rating - The industry is rated as "Strongly Outperforming the Market" [2][36]. Core Viewpoints - The report highlights a decline in domestic photovoltaic module production in November, while the demand for energy storage remains robust [2][5]. - The production forecast for December indicates a 5.3% month-on-month increase in battery production, with energy storage cells accounting for approximately 35.3% of the total [2][12]. - The report suggests focusing on companies related to photovoltaic and energy storage sectors, recommending specific stocks such as Sunshine Power, Nandu Power, and others [2][36]. Summary by Sections Production - In November 2025, the overall production of photovoltaic modules decreased by 2.43% compared to October [2][5]. - The forecast for December indicates a total production of 220 GWh for the Chinese market, with a month-on-month growth of 5.3% [2][12]. Prices - As of December 3, 2025, the price of polysilicon remained stable at 52.00 CNY/kg, while the average price of 183N monocrystalline silicon wafers decreased slightly to 1.18 CNY/piece [2][12]. - The average bid price for lithium iron phosphate battery energy storage systems in October was 0.5547 CNY/Wh, reflecting a 10% month-on-month increase [2][20]. Domestic Demand - In October 2025, the domestic photovoltaic installation capacity increased by 30.4% month-on-month, totaling 12.6 GW, while the cumulative installation for the year reached 252.87 GW, a 39.5% year-on-year increase [2][22]. - The energy storage sector saw a significant increase in new tender projects, with a year-on-year growth of 85% [2][28]. Overseas Demand - In October 2025, the export value of photovoltaic modules was approximately 2.258 billion USD, showing a year-on-year increase of 4.39% [2][32]. - The report notes a significant growth potential in emerging markets, particularly in Australia, where inverter exports have seen a substantial increase [2][34].